Evidence map›Paper›PMID 29312738›Full record

ArticleJournal of thoracic disease2017

Lina Wang, Shiyuan Zhou, Jiansheng Xie, Huafang Gao, Fengyu Wang, Jiping Zhou, Yanli Wang, Haili Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lina WangPeking Union Medical College Graduate School, Beijing 100730, China.
Shiyuan ZhouKey Laboratory of Birth defects Prevention, National Health and Family Planning Commission, Zhengzhou 450002, China.
Jiansheng XiePrenatal Diagnosis Center, Shenzhen Maternal and Child Health Hospital, Shenzhen 518040, China.
Huafang GaoNational Research Institute for Health and Family Planning, Beijing 100081, China.
Fengyu WangKey Laboratory of Birth defects Prevention, National Health and Family Planning Commission, Zhengzhou 450002, China.
Jiping ZhouKey Laboratory of Birth defects Prevention, National Health and Family Planning Commission, Zhengzhou 450002, China.
Yanli WangKey Laboratory of Birth defects Prevention, National Health and Family Planning Commission, Zhengzhou 450002, China.
Haili WangKey Laboratory of Birth defects Prevention, National Health and Family Planning Commission, Zhengzhou 450002, China.
National Health and Family Planning Commission · CNPeking Union Medical College Hospital · CNShenzhen Maternity and Child Healthcare Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGene mutations of

methodsComprehensive

resultsAbout 52.54% (31/59) of familiar breast cancer patients showed

conclusions

Indexed as

BRCABreast cancerdenaturing high-performance liquid chromatography (DHPLC)germline mutation

Identifiers

PMID29312738
PMCPMC5757050
OpenAlexW2768165325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.